Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis
<p><strong>Objective:</strong> Dimethyl fumarate is a medication approved for the treatment of relapsing-remitting multiple sclerosis. The purpose of the study was to evaluate the safety and persistence of dimethyl fumarate in clinical practice and analyze the occurrence of ly...
Autores principales: | , , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Elsevier
2021-03-01
|
Colección: | Farmacia Hospitalaria |
Materias: | |
Acceso en línea: | http://www.aulamedica.es/fh/pdf/11567.pdf |